🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at age 51 after a personal fight with pancreatic cancer.

“The brilliant light of our family has dimmed his light for us in this life,” his family confirmed. “After a prolonged and brave battle with cancer, we are heartbroken to declare that D’Angelo, known to his followers around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative modern soul style and collaborations with renowned musicians.

He launched his first record, “Brown Sugar,” in the mid-nineties to instant praise. The album reached the fourth spot on Billboard’s Top R&B Albums chart, earned platinum status later that year, and earned several Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his music career into the stratosphere. The record debuted at the top spot on both the R&B charts and the main album chart. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the public consciousness. The intimate portrayal showed the artist, notably bare to his waist, singing straight into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious vehicle accident that put him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the soul music rankings and a Grammy for Top R&B Record.

Again, in his own enigmatic way, D’Angelo had limited public appearances in the subsequent period.

The singer was announced as a headliner for the 2025 music event, but his performance was canceled, citing an “unexpected health issue.”

Even though information is limited about D’Angelo’s well-being in the weeks leading up to his death, he had reportedly been in the hospital for months and in palliative care for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the most deadly and least preventable forms of the illness, on a gifted artist whose life was ended too soon.

“We are grieved that he can only provide dear memories with his loved ones, but we are forever thankful for the legacy of extraordinarily moving music he has left us,” his family expressed.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic cancer impacts the pancreas, a small organ that generates the hormone insulin and plays an essential role in digestion, among additional roles. The size and location of the pancreas in the body make it more challenging to identify cancer.

Even though pancreatic cancer accounts for only about 3% of cancer diagnoses each year in the U.S., it is causes seven percent of malignancy fatalities.

Almost 70,000 individuals will be diagnosed with pancreatic cancer and about 52,000 will succumb to the disease in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and ineffective therapies, and a smaller window to make a significant difference on the well-being of people,” said a medical oncologist.

Since this disease rarely causes initial signs, it’s frequently diagnosed only once the disease is late-stage. Although a individual has symptoms they are often nonspecific and may be confused with a number of common illnesses.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, apart from listening to your body and speaking with your physician if there are unfamiliar symptoms,” said a health expert.

Frequent indicators of pancreatic cancer encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an exception, as this malignancy is most common in adults in the 65 to 75 age bracket. However, numerous malignancies, such as pancreatic cancer, have become increasingly prevalent in younger people.

“This disease diagnosed before the age of 50 is considered uncommon, yet concerningly, clinicians are beginning to see a growing number of younger individuals suffering from this condition,” said a expert.

Genetic Background Affects Cancer Risk

In the absence of reliable screening tools for this malignancy, experts emphasized the importance of knowing your relatives’ cancer history. Certain risk factors, such as smoking and excess weight also have an influence in the development of pancreatic cancer.

African Americans have the greatest occurrence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The initial action toward reducing one’s risk of this condition is understanding personal risk factors. Individuals should review their family history, hereditary factors, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or obesity that may increase their susceptibility,” said a specialist.

Inherited genetic risk factors are linked to as much as 10% of all this malignancy instances. If someone in your family has had this disease, you may want to think about DNA analysis.

“For individuals with a family history of pancreatic cancer or those having elevated risk DNA changes, screening may involve sophisticated scans such as MRI scans or internal ultrasound to detect initial alterations in the pancreas,” he clarified.

For those looking to lower their chance, habit adjustments may have an effect. The best step you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Heavy alcohol consumption is linked to pancreas inflammation, a risk factor for this malignancy, so reducing or abstaining from drinks may assist reduce your risk.

Controlling your body mass or losing weight may also help reduce your risk. People with obesity are 20% more likely to develop pancreatic cancer. This malignancy also is more frequent in those with blood sugar issues, and reducing weight can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and more recent mixed drug treatments. There are emerging targeted therapies that are already showing results,” remarked a expert.

For many people, however, awareness about this rare but {dev